Keywords
Last Name
Institution

Funding Agency: Merck Research Laboratories
Title: A Phase I, Single-Dose, Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate in Inpatients Under 2 Years Old
Start Date: 2017-05-01


Collapse Overview 
Collapse researcher role of